This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Rashmi Hedge: Innovator in Fibrosis Treatment
Introduction
Rashmi Hedge is a prominent inventor based in Cincinnati, OH (US). She has made significant contributions to the field of medical research, particularly in the treatment of fibrosis. Her innovative work focuses on developing methods to address scarring in various organs, which can have profound implications for patient care.
Latest Patents
Rashmi Hedge holds a patent for the "Administration of DKK1 muteins to treat fibrosis." This patent outlines molecules, compositions, and methods designed to treat scarring by modulating critical signaling pathways, including WNT, platelet-derived growth factor receptor (PDGFR), transforming growth factor-beta (TGF3), and connective-tissue growth factor (CTGF). This groundbreaking work represents a significant advancement in the treatment of fibrotic conditions.
Career Highlights
Rashmi Hedge is affiliated with the University of Washington, where she continues to push the boundaries of research in her field. Her dedication to innovation and excellence has established her as a leading figure in the medical research community.
Collaborations
Rashmi has collaborated with esteemed colleagues, including Jeremy Duffield and Shuyu Ren. These partnerships have further enhanced her research efforts and contributed to the advancement of knowledge in fibrosis treatment.
Conclusion
Rashmi Hedge's work exemplifies the spirit of innovation in medical research. Her contributions to the treatment of fibrosis through her patented methods are paving the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile